The purpose of this study is to test the amount of caspofungin found in the blood of neonate and infants \<3 months of age following treatment with caspofungin at 25 mg/m2. Another purpose is to test the safety of caspofungin in treating neonates and infants with Candida infections (a certain type of fungal infection).
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
16
Duration of Treatment 28 Days
Pharmacokinetic parameters of drug exposure
Safety and tolerability
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.